Business Description
Enzymatica AB
ISIN : SE0003943620
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 5.06 | |||||
Beneish M-Score | -3.28 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -26.4 | |||||
3-Year EBITDA Growth Rate | -89.7 | |||||
3-Year EPS without NRI Growth Rate | -49.4 | |||||
3-Year FCF Growth Rate | -32.2 | |||||
3-Year Book Growth Rate | -14.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | -2.56 | |||||
Future 3-5Y Total Revenue Growth Rate | 60.11 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.36 | |||||
9-Day RSI | 33.87 | |||||
14-Day RSI | 39.14 | |||||
6-1 Month Momentum % | -18.94 | |||||
12-1 Month Momentum % | -24.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.45 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 0.65 | |||||
Days Inventory | 285.16 | |||||
Days Sales Outstanding | 61.36 | |||||
Days Payable | 144.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -7.6 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 63.99 | |||||
Operating Margin % | -121.14 | |||||
Net Margin % | -124.47 | |||||
FCF Margin % | -100.58 | |||||
ROE % | -65.95 | |||||
ROA % | -42.22 | |||||
ROIC % | -49.28 | |||||
ROC (Joel Greenblatt) % | -272.99 | |||||
ROCE % | -48.14 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.6 | |||||
PB Ratio | 5.07 | |||||
EV-to-EBIT | -8.41 | |||||
EV-to-Forward-EBIT | -54.32 | |||||
EV-to-EBITDA | -8.41 | |||||
EV-to-Forward-EBITDA | -60.35 | |||||
EV-to-Revenue | 10.13 | |||||
EV-to-Forward-Revenue | 5.08 | |||||
EV-to-FCF | -10.57 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Earnings Yield (Greenblatt) % | -11.89 | |||||
FCF Yield % | -10.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Enzymatica AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.94 | ||
EPS (TTM) (€) | -0.028 | ||
Beta | 1.06 | ||
Volatility % | 36.45 | ||
14-Day RSI | 39.14 | ||
14-Day ATR (€) | 0.006579 | ||
20-Day SMA (€) | 0.147575 | ||
12-1 Month Momentum % | -24.94 | ||
52-Week Range (€) | 0.121572 - 0.325948 | ||
Shares Outstanding (Mil) | 242.74 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Enzymatica AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Enzymatica AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Enzymatica AB Frequently Asked Questions
What is Enzymatica AB(FRA:EN9)'s stock price today?
When is next earnings date of Enzymatica AB(FRA:EN9)?
Does Enzymatica AB(FRA:EN9) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |